Work

An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus

Year: 2008

Type: article

Source: Arthritis & Rheumatism

DOI: 10.1002/art.23428

Authors: Frances Rena Bahjat, Polly R. Pine, Andrea Reitsma, Gail Cassafer, Muhammad Baluom, Sunny Grillo, Betty Chang, Fei Fei Zhao, Donald G. Payan, Elliott B. Grossbard, David I. Daikh

Institutions: Rigel (United States), San Francisco VA Medical Center, University of California, San Francisco

Language: English

Topic: Systemic Lupus Erythematosus Research

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2045549010

FWCI: 11.51

Cites: 51

Cited by: 171

Related to: 10